The central cannabinoid receptor type-2 (CB2) and chronic pain

被引:29
作者
Shang, Yuchao [1 ,2 ]
Tang, Yuying [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp 2, Dept Anesthesiol, Chengdu, Peoples R China
[2] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Cannabinoid; CB2; pain; analgesia; clinical; RANDOMIZED CONTROLLED-TRIAL; CHRONIC NEUROPATHIC PAIN; INCREASES INTRACELLULAR CALCIUM; ACTIVATED PROTEIN-KINASE; SPINAL DORSAL-HORN; MULTIPLE-SCLEROSIS; GLIAL ACTIVATION; NERVE INJURY; PHARMACOLOGICAL CHARACTERIZATION; IN-VITRO;
D O I
10.1080/00207454.2016.1257992
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoid receptor type-2 (CB2, CB2 receptor or CB2-R) mediates analgesia via two mechanisms. CB2 receptors contained in peripheral immune tissue mediate analgesia by altering cytokine profiles, and thus have little adverse effects on central nervous systems (CNSs). CB2 is also expressed in the neurons and glial cells of the CNS. This neuronal expression may also contribute to pain attenuation. The CB2 receptor has been proposed as a potential target in treating chronic pain of several etiologies.
引用
收藏
页码:812 / 823
页数:12
相关论文
共 50 条
  • [31] Activation of the Cannabinoid 2 Receptor (CB2) Protects Against Experimental Colitis
    Storr, Martin A.
    Keenan, Catherine M.
    Zhang, Hong
    Patel, Kamala D.
    Makriyannis, Alexandros
    Sharkey, Keith A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (11) : 1678 - 1685
  • [32] Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
    Whiting, Zak M.
    Yin, Jiazhen
    de la Harpe, Sara M.
    Vernall, Andrea J.
    Grimsey, Natasha L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (09) : 754 - 771
  • [33] The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
    Ashton, John C.
    Glass, Michelle
    CURRENT NEUROPHARMACOLOGY, 2007, 5 (02) : 73 - 80
  • [34] Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders
    Bala, Kanchan
    Porel, Pratyush
    Aran, Khadga Raj
    PSYCHOPHARMACOLOGY, 2024, 241 (10) : 1939 - 1954
  • [35] NEURONAL EXPRESSION OF CB2 CANNABINOID RECEPTOR mRNAs IN THE MOUSE HIPPOCAMPUS
    Li, Y.
    Kim, J.
    NEUROSCIENCE, 2015, 311 : 253 - 267
  • [36] Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
    Ashton, JC
    Friberg, D
    Darlington, CL
    Smith, PF
    NEUROSCIENCE LETTERS, 2006, 396 (02) : 113 - 116
  • [37] Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain
    Nozaki, Chihiro
    Nent, Elisa
    Bilkei-Gorzo, Andras
    Zimmer, Andreas
    SCIENTIFIC REPORTS, 2018, 8
  • [38] What we know and do not know about the cannabinoid receptor 2 (CB2)
    Malfitano, Anna Maria
    Basu, Sreemanti
    Maresz, Katarzyna
    Bifulco, Maurizio
    Dittel, Bonnie N.
    SEMINARS IN IMMUNOLOGY, 2014, 26 (05) : 369 - 379
  • [39] Updating the Chemistry and Biology of Cannabinoid CB2 Receptor-Specific Inverse Agonists
    Lunn, Charles A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 768 - 778
  • [40] Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation
    Carruthers, Emma R. R.
    Grimsey, Natasha L. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (14) : 2247 - 2269